Harvard Business Review
JANUARY 28, 2011
If determining whether your employees are losing their ability to effectively process ideas and information costs next to nothing , aren't you ethically obligated to find that out? While personal and professional pain around the likely loss of one's faculties is unavoidable, the legal and ethical implications have only begun to be addressed.
Strategy Driven
MAY 25, 2011
That’s when the usual ethical and moral constraints are sometimes abandoned – always for good reasons, and always ‘just this once’ – in the name of expediency. That’s why, inevitably, there is a constant pressure to let the end justify the means. Sometimes this strategy even works. About the Author.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Strategy Driven
MAY 25, 2011
That’s when the usual ethical and moral constraints are sometimes abandoned – always for good reasons, and always ‘just this once’ – in the name of expediency. That’s why, inevitably, there is a constant pressure to let the end justify the means. Sometimes this strategy even works. About the Author.
Harvard Business Review
JUNE 8, 2015
Within EB, Merck first created a Global Health Innovation Fund and then a Healthcare Services and Solution unit to identify, develop, and operate nascent opportunities that fit that thesis. For ideas to become reality, a company needs repeatable processes, not only out-of-the-box insights. Experimentation is vital.
Harvard Business Review
JANUARY 12, 2018
Companies are both operators and investors. Further, venture capitalists are jumping in with both feet. $4 Companies in every industry can benefit from making more data and algorithm-based decisions in areas of internal operations and finance. Shift to providing advice on business models, not just strategy and operations.
Expert insights. Personalized for you.
15 
Let's personalize your content